Mark Broadwin

13PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsMedical devicesMolecular targetsCardiology (incl. cardiovascular diseases)Energy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 19, 2026
Semaglutide augments vascular proliferation and cardiac performance in a large animal model of ischemic cardiomyopathy.

Kelsey C Muir, Christopher Stone, Dwight D Harris

|Mar 13, 2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome.

Dwight D Harris, Mark Broadwin, Christopher Stone

|Dec 20, 2024
Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemia.

Mark Broadwin, Katerina St Angelo, Max Petersen

|Dec 12, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease.

Christopher Stone, Dwight D Harris, Mark Broadwin

|Aug 30, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease.

Christopher R Stone, Dwight D Harris, Mark Broadwin

Pageof 3